Free Trial

Humacyte (HUMA) SEC Filings & 10K Form

Humacyte logo
$2.28 -0.12 (-5.00%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.26 -0.02 (-0.83%)
As of 08/1/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Humacyte SEC Filings

DateFilerForm TypeView
06/16/2025
3:30 PM
Bamforth John Philip (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:31 PM
Constantino Michael T. (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:31 PM
Green Charles Bruce (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:31 PM
Dougan Brady W (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:31 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Niklason Laura E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:31 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Windham-Bannister Susan Richards (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:32 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Wallace Max N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:32 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Jones Keith Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:32 PM
Brown Emery N. (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
3:32 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Pope Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
3:08 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2025
2:23 PM
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ (Filed by)
Humacyte (Subject)
Humacyte, Inc. (Subject)
Form SCHEDULE 13D/A
05/13/2025
4:11 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
6:36 AM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
3:10 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form PRE 14A
04/14/2025
8:00 AM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Parikh Shamik J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
8:00 AM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Sander Dale A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
3:39 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/28/2025
6:55 AM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
4:17 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
3:39 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 424B5
03/26/2025
3:48 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
3:30 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 424B3
01/23/2025
3:34 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Parikh Shamik J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:34 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Sander Dale A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:34 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Niklason Laura E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:34 PM
Dougan Brady W (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:34 PM
Cao Yang (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:34 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Scheessele William John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:35 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Prichard Heather Ledbetter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:09 PM
Dougan Brady W (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:09 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Prichard Heather Ledbetter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:09 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Sander Dale A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:09 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Niklason Laura E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:25 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
6:30 AM
Dougan Brady W (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
6:31 AM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Niklason Laura E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
6:02 PM
Dougan Brady W (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
6:06 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Niklason Laura E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
6:10 PM
Humacyte (Subject)
Humacyte, Inc. (Subject)
Niklason Laura E (Filed by)
Form SC 13D/A
11/14/2024
7:17 AM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 424B3
Jeff Bezos Launches "ChatGPT Killer"? (Ad)

Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% of his time focused on AI… but Nova is only part of the story. Behind the scenes, Amazon has been quietly investing in a breakthrough called “Helios” tech—a core enabler of the $40 trillion AI revolution. While Nova grabs headlines, this technology could be what truly transforms Amazon’s future. But one tiny startup—not Amazon—may offer the bigger upside.

Get the name of the small company at the center of the $40 trillion AI boom.
11/08/2024
7:04 AM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:07 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Humacyte (Subject)
Humacyte, Inc. (Subject)
Form SC 13G
10/07/2024
5:06 AM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:01 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 424B3
09/25/2024
5:00 AM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 424B3
09/16/2024
3:36 PM
Green Charles Bruce (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:50 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Niklason Laura E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:52 PM
Dougan Brady W (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:53 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Sebelius Kathleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
9:41 AM
Humacyte (Subject)
Humacyte, Inc. (Subject)
Sebelius Kathleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
3:19 PM
Ayabudge LLC (Reporting)
Humacyte (Subject)
Humacyte, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
3:23 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Niklason Laura E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:45 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Sander Dale A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:48 PM
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Niklason Laura E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
5:52 PM
Dougan Brady W (Reporting)
Humacyte (Issuer)
Humacyte, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:31 PM
Ayabudge LLC (Reporting)
Humacyte (Subject)
Humacyte, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
3:41 PM
Ayabudge LLC (Reporting)
Humacyte (Subject)
Humacyte, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
3:47 PM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:04 AM
Humacyte (Filer)
Humacyte, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HUMA) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners